|Datasheet||Specific References||Reviews||Related Products||Protocols|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Ferret IL1RN ORF mammalian expression plasmid, C-GFPSpark tag||FG60143-ACG|
|Ferret IL1RN ORF mammalian expression plasmid, C-OFPSpark / RFP tag||FG60143-ACR|
|Ferret IL1RN ORF mammalian expression plasmid, C-Flag tag||FG60143-CF|
|Ferret IL1RN ORF mammalian expression plasmid, C-His tag||FG60143-CH|
|Ferret IL1RN ORF mammalian expression plasmid, C-Myc tag||FG60143-CM|
|Ferret IL1RN ORF mammalian expression plasmid, C-HA tag||FG60143-CY|
|Ferret IL1RN Gene cDNA clone plasmid||FG60143-G|
|Ferret IL1RN ORF mammalian expression plasmid, N-Flag tag||FG60143-NF|
|Ferret IL1RN ORF mammalian expression plasmid, N-His tag||FG60143-NH|
|Ferret IL1RN ORF mammalian expression plasmid, N-Myc tag||FG60143-NM|
|Ferret IL1RN ORF mammalian expression plasmid, N-HA tag||FG60143-NY|
|Ferret IL1RN natural ORF mammalian expression plasmid||FG60143-UT|
|Learn more about expression Vectors|
Interleukin-1 receptor antagonist (IL-1RA) also known as IL1RN is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses. A polymorphism of this protein encoding gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer. IL-1RA/IL1RN may inhibit the activity of IL-1 by binding to its receptor and it has no IL-1 like activity. Genetic variation in IL-1RA/IL1RN is associated with susceptibility to microvascular complications of diabetes type 4 (MVCD4). These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Defects in IL-1RA/IL1RN are the cause of interleukin 1 receptor antagonist deficiency (DIRA) which is also known as deficiency of interleukin 1 receptor antagonist. Autoinflammatory diseases manifest inflammation without evidence of infection, high-titer autoantibodies, or autoreactive T-cells. DIRA is a rare, autosomal recessive, genetic autoinflammatory disease that results in sterile multifocal osteomyelitis, and pustulosis from birth.